Yeah, well I am certainly not Eugene (or U'Gene for that...

Yeah, well I am certainly not Eugene (or U'Gene for that matter).

Analalogy to the slick (no pun intended), vacuous, moronic world of corporate liquor advertising doesn't do it for me. That is the province of the sporting world who promote a lifestyle of alcoholism, obesity and poverty via their champion sponsors, namely, alcohol, fast food and gambling. All done under the guise of amusing slickness, cuteness and the fast, aspirational good life. Their lasting legacy is to promote physical and mental unwellness. Yeah (again), with the big C high on the list. Leave me out of all that crap.

But back on point. True a (big) deal could come at any time, but I have the feeling that is highly unlikely at this stage. Far too much competition in immuno oncology and far too little progress along the efficacy pathway to date. We need written up and followed up P1b data and then, the big one, P2 results. And all along that timeline the whole thing could unravel. The risk, although promising at this stage, is still quite large as human trials are in their infancy.

I prefer to look at the next step, rather than envisage future riches. Something positive in the P1b follow up data would do me fine. Something that would give the SP a real floor lift. Would love to see the traders operating at (say) 4c instead of the current puny price. However, the actualization of such news is certainly no certainty.